Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Mimedx (MDXG) EBIAT (2016 - 2025)

Historic EBIAT for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $16.7 million.

  • Mimedx's EBIAT rose 10689.31% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.8 million, marking a year-over-year decrease of 5267.48%. This contributed to the annual value of $42.4 million for FY2024, which is 3710.02% down from last year.
  • As of Q3 2025, Mimedx's EBIAT stood at $16.7 million, which was up 10689.31% from $9.6 million recorded in Q2 2025.
  • Mimedx's EBIAT's 5-year high stood at $51.3 million during Q4 2023, with a 5-year trough of -$10.9 million in Q2 2022.
  • Its 5-year average for EBIAT is $5.1 million, with a median of $7.0 million in 2025.
  • Its EBIAT has fluctuated over the past 5 years, first plummeted by 51090.5% in 2022, then soared by 1248840.58% in 2023.
  • Over the past 5 years, Mimedx's EBIAT (Quarter) stood at $199000.0 in 2021, then tumbled by 308.04% to -$414000.0 in 2022, then soared by 12488.41% to $51.3 million in 2023, then tumbled by 85.5% to $7.4 million in 2024, then skyrocketed by 125.17% to $16.7 million in 2025.
  • Its last three reported values are $16.7 million in Q3 2025, $9.6 million for Q2 2025, and $7.0 million during Q1 2025.